肠道质在与子宫内膜异位症相关的IBS类结肠炎症中的参与
Luis A Rivera-Arce1, Myrella L Cruz1, Ulises Rodriguez-Cintron1
1Department of Basic Sciences - Physiology Division, Ponce Health Sciences University, Ponce Research Institute, PO Box 7004, Ponce, 00732-7004, PR, Puerto Rico.
BMC women's health
|December 20, 2024
概括
子宫内膜异位症会引起胃肠道问题和炎症,因为它会影响结肠和大肠. 这项研究表明,子宫内膜异位症会诱导反应性滑体和巨细胞的透,模仿刺激性肠综合征 (IBS) 组织病理学.
科学领域:
- 胃肠病学 胃肠病学
- 妇科 妇科 妇科 妇科
- 神经科学是一个神经科学.
背景情况:
- 子宫内膜异位症的特征是异位子宫内膜组织,显著影响患者的生活质量.
- 胃肠道 (GI) 症状,如胀气和改变肠道习惯,在子宫内膜异位症中很常见,往往导致误诊为刺激性肠道综合征 (IBS).
- 肠质细胞 (EGC) 参与IBS疼痛,但它们在子宫内膜异位症中的作用尚不清楚.
研究的目的:
- 在动物模型中研究子宫内膜异位症对胃肠道的影响.
- 为了确定子宫内膜异位症是否会在结肠的骨髓中诱导反应性质化.
- 评估状纤维酸蛋白 (GFAP) 和S100B表达的变化.
主要方法:
- 使用了一种手术诱导的子宫内膜异位症大鼠模型.
- 组织学分析包括对微观损伤进行H&E染色和对巨细胞透进行托卢伊丁蓝色染色.
- 免疫光被用来测量GFAP和S100B在结肠部分的表达.
主要成果:
- 子宫内膜异位症诱导显著的宏观结肠损伤.
- 来自子宫内膜异位症大鼠的阴茎切片显示,与对照组相比,杆细胞透率增加.
- GFAP免疫染色显示,子宫内膜异位症大鼠结肠中综合密度显著增加.
结论:
- 子宫内膜异位症会改变肠道平衡,导致结肠炎症和反应性化.
- 乳腺巨细胞透也是一种子宫内膜异位症的后果.
- 这些发现表明子宫内膜异位症可以在组织病理上模仿IBS,突显了疾病的复杂性和综合治疗方法的需要.
更多相关视频
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
244
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
244
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135
01:30Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183
01:17Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
01:17Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
139
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
139